Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Xylometazoline (0.01% w/v)
Therapeutic Category
Cold and Cough, General and OTC medicines, Pulmonary, Respiratory, ENT
Dosage Form
Nasal Spray
Packaging Type
Bottle
Packaging
10ml
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Nosniff Mini Nasal Spray is a gentle and effective decongestant specially formulated for infants and young children to provide instant relief from nasal congestion. It contains Xylometazoline, a topical nasal decongestant, at a low concentration of 0.01% w/v, making it safe and suitable for pediatric use. The spray works by narrowing the blood vessels in the nasal passages, which helps reduce swelling and clears the airways, enabling easier breathing. This product is ideal for managing symptoms associated with common colds, allergies, sinusitis, and upper respiratory tract infections.
Nosniff Mini Nasal Spray comes in a convenient spray bottle, ensuring accurate dosing and minimal wastage. It provides quick and lasting relief, allowing children to sleep better and improve overall comfort during colds or allergic reactions.
Mild side effects may include temporary nasal irritation, dryness, or a slight burning sensation. Rarely, prolonged use may cause rebound congestion.
Used for temporary relief of nasal congestion due to colds, allergies, or sinusitis in infants and young children.
Use only as directed by a healthcare provider. Avoid prolonged use to prevent dependency or rebound congestion.
Store in a cool, dry place below 30°C. Keep away from direct sunlight and out of reach of children.
Composition : Xylometazoline (0.05% w/v)
Composition : Oxymetazoline (0.025% w/v)
Composition : Sodium Chloride I.P. 0.65% w/v + Benzalkonium Chloride Solution I.P. 0.02% w/v Nasal Drop
Composition : Fluticasone Furoate (50mcg)
Composition : Fluticasone Furoate (27.5mcg)
Composition : Fluticasone Furoate (27.5mcg) + Azelastine (140mcg)
Composition : Mometasone (50mcg)
Composition : Fluticasone Propionate (0.005% w/v)
Composition : Xylometazoline (0.1% w/v)
Composition : Levosalbutamol (50mcg) + Ipratropium (20mcg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Xylometazoline 0.01% Nasal Spray is a nasal decongestant (sympathomimetic agent) used for the relief of blocked nose due to cold, allergic rhinitis, sinusitis, and upper respiratory tract infections. It works by constricting nasal blood vessels, reducing swelling and improving airflow. It is a strong ENT and respiratory OTC/prescription segment product, commonly used in hospitals, clinics, and home care.
Medical distributors and wholesalers can benefit from very high seasonal demand, especially during cold, flu, allergy, and monsoon seasons. It is a fast-moving OTC + prescription product, ensuring strong retail turnover and repeat purchases.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in ENT, respiratory, and OTC nasal care segments with monopoly rights, quality manufacturing standards, and reliable supply support for distributors and medical agencies.
Wholesalers and medical agencies benefit from high seasonal demand, strong pharmacy movement, and repeated patient usage in allergy and cold cases, making it a fast-moving and stable pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in ENT and nasal care formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the respiratory and OTC segment.